Show Search Form
human indexable | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||
registered interest | |||||||||||
answer date | |||||||||||
date | |||||||||||
date tabled | |||||||||||
answering body |
|
||||||||||
question status | Tabled | ||||||||||
answering dept id | 17 | ||||||||||
answering dept short name | Health | ||||||||||
answering dept sort name | Health | ||||||||||
ddp created |
|
||||||||||
ddp modified |
|
||||||||||
hansard heading | Financial Services: Greater London | ||||||||||
house id | 2 | ||||||||||
identifier | HL814 | ||||||||||
legislature |
|
||||||||||
parliament number | 56 | ||||||||||
question first answered |
|
||||||||||
question text | Her Majesty's Government how many individuals infected with blood contaminated by hepatitis C or HIV in the 1970s and 1980s remain alive. | ||||||||||
session |
|
||||||||||
session number | 2 | ||||||||||
tabling member printed |
|
||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL814 | ||||||||||
type |
|
||||||||||
uin | HL814 | ||||||||||
version | 1 | ||||||||||
written parliamentary question type | Ordinary | ||||||||||
answer | answer | ||||||||||
creator |
|
||||||||||
publisher |
|
||||||||||
tabling member |
|
human indexable | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||
registered interest | |||||||||||
answer date | |||||||||||
date | |||||||||||
date tabled | |||||||||||
ddp created | |||||||||||
answering body |
|
||||||||||
question status | Tabled | ||||||||||
answering dept id | 17 | ||||||||||
answering dept short name | Health | ||||||||||
answering dept sort name | Health | ||||||||||
ddp modified |
|
||||||||||
hansard heading | Ferries: Isles of Scilly | ||||||||||
house id | 2 | ||||||||||
identifier | HL596 | ||||||||||
legislature |
|
||||||||||
parliament number | 56 | ||||||||||
question first answered |
|
||||||||||
question text | Her Majesty's Government why data on the use of Guidance on Risk Assessment and Stroke Prevention for Atrial Fibrillation is no longer collected as part of the Medicines Optimisation Dashboard. | ||||||||||
session |
|
||||||||||
session number | 2 | ||||||||||
tabling member printed |
|
||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL596 | ||||||||||
type |
|
||||||||||
uin | HL596 | ||||||||||
version | 1 | ||||||||||
written parliamentary question type | Ordinary | ||||||||||
answer | answer | ||||||||||
creator |
|
||||||||||
publisher |
|
||||||||||
tabling member |
|
human indexable | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||
registered interest | |||||||||||
answer date | |||||||||||
date | |||||||||||
date tabled | |||||||||||
answering body |
|
||||||||||
question status | Tabled | ||||||||||
answering dept id | 17 | ||||||||||
answering dept short name | Health | ||||||||||
answering dept sort name | Health | ||||||||||
ddp created |
|
||||||||||
ddp modified |
|
||||||||||
hansard heading | Type 45 Destroyers | ||||||||||
house id | 2 | ||||||||||
identifier | HL597 | ||||||||||
legislature |
|
||||||||||
parliament number | 56 | ||||||||||
question first answered |
|
||||||||||
question text | Her Majesty's Government what proportion of GP surgeries use (1) the Guidance on Risk Assessment and Stroke Prevention for Atrial Fibrillation tool, and (2) other tools, to audit the management of atrial fibrillation patients, broken down by clinical commissioning group, in each of the last five years for which figures are available. | ||||||||||
session |
|
||||||||||
session number | 2 | ||||||||||
tabling member printed |
|
||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL597 | ||||||||||
type |
|
||||||||||
uin | HL597 | ||||||||||
version | 1 | ||||||||||
written parliamentary question type | Ordinary | ||||||||||
answer | answer | ||||||||||
creator |
|
||||||||||
publisher |
|
||||||||||
tabling member |
|
human indexable | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||
registered interest | |||||||||||
answer date | |||||||||||
date | |||||||||||
date tabled | |||||||||||
answering body |
|
||||||||||
question status | Tabled | ||||||||||
answering dept id | 17 | ||||||||||
answering dept short name | Health | ||||||||||
answering dept sort name | Health | ||||||||||
ddp created |
|
||||||||||
ddp modified |
|
||||||||||
hansard heading | Special Educational Needs: Finance | ||||||||||
house id | 2 | ||||||||||
identifier | HL598 | ||||||||||
legislature |
|
||||||||||
parliament number | 56 | ||||||||||
question first answered |
|
||||||||||
question text | Her Majesty's Government what proportion of patients diagnosed with atrial fibrillation are treated with (1) anticoagulant therapy, and (2) antiplatelet therapy, broken down by clinical commissioning group, in each of the last five years for which figures are available. | ||||||||||
session |
|
||||||||||
session number | 2 | ||||||||||
tabling member printed |
|
||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL598 | ||||||||||
type |
|
||||||||||
uin | HL598 | ||||||||||
version | 1 | ||||||||||
written parliamentary question type | Ordinary | ||||||||||
answer | answer | ||||||||||
creator |
|
||||||||||
publisher |
|
||||||||||
tabling member |
|